Lilly Acquires Ventyx Biosciences: Boosting Oral Treatments for Inflammatory Diseases Posted by 0 on January 08, 2026 Acquisition Autoimmune Disease Clinical Trials Drug Development Eli Lilly Inflammatory Diseases M&A Oral Therapies Pharmaceuticals USA Ventyx Biosciences +